Almac Receives OAPI Award

Almac’s Clinical Services team was presented an award by Brent Kelly, Otsuka America Pharmaceutical Inc.’s (OAPI) director of Clinical Supply Operations during a visit to Almac’s North American Headquarters in Souderton, PA in June. Almac provided clinical supply services for OAPI’s Abilify Maintena (aripiprazole) clinical trial program, supporting the approval of the once-monthly injectable treatment for schizophrenia earlier in 2013. The award recognized Almac’s commitment to quality, customer service, and operational excellence.
 
Celine Bradley, Almac’s global vice president of operations, said, “I am proud to receive this award from one of our valued customers, and I would like to congratulate OAPI on their successful registration of the Abilify Maintena product. Almac’s core values include our commitment to quality and customer focus, and it is very satisfying to have a client recognize when we have delivered on these. I would like to commend the Almac team for their dedication to successful and timely completion of this project. Awards like this highlight the importance of clinical trial supply in enabling our partners to make a real difference in patients’ lives.”